The possibility of introducing a computationally-assisted method to study aptamer- 
Introduction
Aptamers, single stranded nucleic acids generated in vitro, have been extensively used in many analytical applications, such as chromatography, electrophoresis, mass spectrometry, molecular beacons, sensors and biosensors. In particular, aptamers have become increasingly important molecular tools for diagnostics and therapeutics, while also offering great flexibility for the design of novel biosensors with high detection sensitivity and selectivity (1-2).
The Systematic Evolution of Ligands by EXponential enrichment procedure (SELEX) is a powerful tool for screening large libraries of randomised nucleic acids (generally 10 13 -10 15 different structures), generated by combinatorial chemistry (3) . Experimentally, the selection of a proper ligand to attain a desired structure is largely a subject of trial and error, due to the large number of possible
candidates to be synthesised and tested using a combinatorial approach. The use of molecular modelling software potentially offers a considerable assistance for the rational design of molecular systems with high selectivity and affinity (4-7).
Moreover some of the drawbacks encountered in the generation of aptamers by the SELEX process could be avoided with the help of a computationally-assisted method. The introduction of a rationalised approach which makes use of a predictive model could overcome or minimise experimental problems currently encountered with the SELEX process, such as reagent stability and separation procedures (8) (9) , non-specific recognition of the support and the fact that pcr tends not to amplify secondary structures. Moreover, a method to partially preselect aptamer sequences that are more likely to bind the target anylyte, would reduce the practical volumetric problems associated with screening that result in a typical SELEX procedure only searching around 10 14 of a possible 10 18 sequences.
Computational approaches are routinely applied to identify candidate compounds for new drugs using information obtained from the target structure, because of the necessity to use cost-and time-effective ways to indentify lead compounds (10) .
The strength and type of interactions existing between ligands and target determine the recognition properties of the complex. In principle, the ligands with the highest binding score are the best candidates for use in molecular recognition systems.
In this work, the possibility of introducing a molecular modelling method to study aptamer-protein interaction and aptamer selection was evaluated with the aim of introducing a novel and streamlined technique to find new aptamers. Other comparative studies between simulated binding scores obtained from a database of candidates and experimental results, obtained by testing the ability of ligands to bind a target, have been reported, but only with oligopeptides (4) (5) (11) (12) or small organic compounds (13) (14) (15) (16) as potential ligands.
Here, the thrombin-binding aptamer was chosen as a model and a retrospective docking study was performed by comparing the affinity of mutated sequences for thrombin with that of the thrombin-binding aptamer, based on computationallyderived binding score.
The DNA aptamer that binds to thrombin (TBA) was chosen as a model, because it is one of the most well characterised. Its structure has been determined (17) , as well as its binding site (18) (19) and its stability in vivo and in vitro (20) . The 15-mer TBA sequence was identified by SELEX as the minimal consensus sequence (5'-GGTTGGTGTGGTTGG-3') from a pool of ~10 13 96-mer oligonucleotides containing a randomised 60-mer sequence (21) . The crystal structure of the complex thrombin-TBA was solved by X-Ray crystallography (22 (16, (23) (24) (25) (26) (27) (28) (29) (30) (31) .
In this study, the reliability of computational results was tested by experimental measurements. For this purpose, the Thrombin-binding aptamer and other mutated sequences, selected on the basis of their binding score, were employed for the development of optical biosensors and the resulting analytical performances were compared in order to introduce a computational approach to the aptamer selection, thus streamlining the currently experimental selection technique used for aptamer development (32).
Materials and methods

Reagents and apparatus
15-mer DNA sequences were designed using the software package Hyperchem 
Computational assay
The 15-mer TBA aptamer (5'-GGT TGG TGT GGT TGG-3') was drawn as a single strand in helix conformation by means of HyperChem 7.5 and used as a reference structure where mutations have to be introduced. HyperChem allowed the substitution of nucleotide residues with others present in the database. The automatic creation of mutated sequences as single strands in helix conformation in HyperChem 7.5 was realised by using a script equipped with a modifiable input file. For limiting the number of sequences to be generated, the number of mutations to be performed with respect to the TBA sequence, was reduced to one or two, obtaining a library of 990 different sequences. The output file consisted of a set of oligonucleotide structures saved in format .pdb, which is compatible with both the HyperChem 7.5 and Openeye software packages. In order to briefly indicate the mutations performed, the following procedure was adopted: the central number indicating the position in the sequence was positioned between the symbol indicating the nucleotide in the TBA sequence for that position (on the left) and the symbol indicating the mutated nucleotide (on the right). The library was added with three virtually generated sequences, which in literature have been experimentally tested for weakly binding to thrombin:
5'GGT GGT GGT TGT GGT3', having 6 mutations (Mutations T4G, G6T, T7G, G10T, T13G, G15T) with respect to the TBA sequence and referred to as sequence "a" (21).
5'GGT AGG GTC GGA TGG3' (Mutations T4A, T7G, G8T, T9C, T12A) referred to as sequence "b" (36).
5'GGT AGG GCA GGT TGG3' (Mutations T4A, T7G, G8C, T9A), referred to as sequence "c" (36) . Therefore, the library contained 994 different sequences as single strands in helix conformation.
Once the library of 15-mer mutated sequences was generated starting from the TBA sequence, the binding score, the main result of computational screening, After, using Openeye scientific software applications the 994 oligonucleotides were compacted in a single file and fast minimized using Openeye application Szybki1.2.2, using Merck Molecular Force Field (MMFF) max_iter = 4000 (37). To take into account the flexibility of the oligonucleotides, conformers were generated for each library member by means of the application Omega2-2.2.1 a systematic high-throughput conformers generator by Openeye, fixing the maximum quantity of conformers generated to 100. Before calculating the binding score, also the two protein receptors, were prepared. By using the Openeye application FredReceptor, an active site box, defining the general space of the protein where aptamers should fit in and are expected to bind, was designed around both heparin-binding exosite and fibrinogen-binding exosite. 
Experimental assay
For the SPR measurements, the biotinylated aptamer immobilisation was realised on dextran-modified CM5 Biacore chips, according to the final part of the protocol and using the following reaction times (35): sequences had a total score higher than -700.
Taking into consideration the two binding exosites, the mutated sequence G5T,G14A (named "Best") was the top scored in the fibrinogen-binding exosite and the tenth scored in the heparin-binding exosite; the TBA sequence was ranked 192 th and 490 th in the two exosites respectively, the mutated sequence T3C,G11A (named "Medium") was ranked 564 th and 60 th respectively and the mutated sequence T4A,G15C (named "Worst") was bottom ranked in both the binding sites. These binding scores were taken into consideration in the choice of the ligands for the experimental test, in order to have a variety of candidates: the best and worst ranked, for which a huge difference in term of binding scores was highlighted, plus a sequence for which an intermediate behaviour had to be expected. A binding score % was calculated by assigning value 100 to the mutated sequence G5T,G14 ("Best") for the fibrinogen-binding site and to the mutated sequence G6T for the heparin-binding site.
Regarding the three sequences experimentally tested in literature for low-binding, docking of sequence "c" failed in both the exosites, while sequences "a" and "b"
were ranked bottom in both the exosites (binding Score sequence "a": -907 and -713 respectively; binding Score sequence "b": -1023 and -811 respectively).
The simulation results for the most interesting sequences are summarized in 
Experimental tests were conducted in order to verify if the binding scores agreed with the analytical behaviour of the sequences. For this purpose, the 15-mer thrombin-binding aptamer as well as the best sequence, the worst sequence and the sequence with intermediate behaviour resulting from the simulation experiments were immobilised on CM5 Biacore chips, in concentration 0.5 µM, following the procedure described in previous paragraph. To afford each immobilised sequence a certain flexibility, a non oligonucleotide spacer (biotin-TEG tail) was chosen in order to avoid base-pairing, which affects the aptamer's secondary structure. Two chips were employed for each sequence and, from the resulting immobilisation shifts, a similar density of immobilised molecules was estimated considering 1000 RU = 0.8 ng/mm 2 (Biacore User Manual). This density similarity allowed a direct comparison among the different sequences when testing their sensitivity for the detection of thrombin. The results for the immobilisation step are reported in Table 3 . 
Optimisation of experimental conditions with Biacore
As a first optimisation step, SPR measurements were performed in order to determine the optimal aptamer-analyte binding protocol. For this purpose, the 5'-biotinylated 15-mer thrombin aptamer with TEG tail was immobilised onto the SPR chip at a concentration of 0.5 μM. The binding buffer optimised in a previous
work (34) was tested for the dilution of thrombin to 20 nM and the binding with the immobilised aptamer was then monitored. The regeneration solution, studied in a previous work as well (33) , was NaOH at two concentrations 1 or 5 mM depending of the drift to be regenerated, with the aim of releasing the bound analyte from the sensor without affecting the aptamer capacity to bind thrombin. Curve shape suggested that a successful rapid binding to a stable plateau was not achieved when experiments were performed in water; on the contrary, a slow binding was observed, without reaching a plateau during the ligand pulse. This could cause an irreproducible binding, probably due to the binding buffer conditions (Biacore User Manual). Moreover, the protein structure could be affected in a highly diluted environment and then a baseline drift was observed when working in MilliQ water. To overcome these problems, further experiments were performed in order to find the lowest ionic strength that supported a binding curve without departing from the computational conditions. For this reason, the optimised binding buffer was diluted 1:10 or 1:50 with MilliQ water and the resulting solutions were used as running and binding buffer. Using the buffer diluted 1:10, a slight dissociation was observed when 100 nM thrombin was bound to the mutated sequence G5T,G14A ("Best") ( Figure 3 ). On the contrary, using the buffer diluted 1:50 the binding curve did not dissociate at the end of the injection. Therefore, this solution (1 mM TrisHCl, pH 7.4, 2.8 mM NaCl, 0.02 mM 
Comparison between the experimentally tested sequences
Using the binding buffer diluted 1:50, the analytical performances of the four oligonucleotide sequences were compared in terms of signal amplitude, sensitivity (slope), linearity (R 2 ) and reproducibility (CVav %). The results indicated that a slightly better performance was obtained with the mutated sequence G5T,G14A
("Best"), while a slightly worse performance was obtained with the mutated sequence T4A,G15C ("Worst"), in agreement with the simulation findings ( Table   4 ). The behaviours of the TBA and the mutated sequence T3C,G11A ("Medium")
were very similar and intermediate between the other two sequences. As a consequence of the reduction in ionic strength, thrombin was detected in the concentration range 0-50 nM with a minimum detectable amount of the analyte of 5 nM, with all the four sequences tested. In contrast, a thrombin concentration range of 0-10 nM was achieved with the immobilised TBA sequence, using the optimised buffer as binding and running buffer, with a minimum detectable amount of analyte of 0.5 nM.
Sequence
Conclusion
The possibility of introducing a computational method for aptamer selection was 
